About Dr. Manish Singhal
Dr. Manish Singhal is a highly respected and experienced Medical Oncologist based in Delhi. With over two decades dedicated to oncology, he brings a wealth of knowledge and expertise, particularly sharpened during his training at India’s premier medical institution, AIIMS (MD, DM). Dr. Singhal is also European Certified in Medical Oncology (ECMO), holding a Gold Medal for topping the exam globally in 2013 and he is the first Indian to recieve this award. His areas of special interest include Breast, Lung, Gastrointestinal, and Genito-urinary cancers, alongside haematological malignancies. Known for his patient-centric approach, compassionate care, and fluency in English, Hindi, and Punjabi, Dr. Manish Singhal is committed to providing personalized, evidence-based treatment using the latest advancements like immunotherapy and targeted therapy. His dedication stems from a personal connection, making him a sought-after oncologist for those seeking the best cancer care in Delhi NCR.
OPD Schedule Of Dr. Manish Singhal
Consultation Fees Rs. 1500 /-
Indraprastha Apollo Hospital, New Delhi
- MBBS, Seth GS Medical College & KEM Hospital, Mumbai (Mumbai University) (1996-2002)
- MD (Internal Medicine), Post Graduate Institute of Medical Sciences (PGIMS), Rohtak (Maharishi Dayanand University) (2003-2006)
- DM (Medical Oncology), AIIMS, New Delhi (2007-2010)
- Hematopoietic Stem Cell Transplant Training, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA (Sep-Oct 2009)
- Randomised Controlled Clinical Trial Course, Oriel College, Oxford University, UK (Sep 2009)
- ECMO (European Certification in Medical Oncology), Certified by the European Society for Medical Oncology, Gold Medal Awardee (2013)
- Breast Cancer
- Lung Cancer
- Gastrointestinal (GI) Cancers (Colon, Stomach, Liver, Pancreatic, etc.)
- Genitourinary (GU) Cancers (Prostate, Kidney, Bladder, Testicular, Urothelial etc.)
- Gynecological Cancers (Ovarian, Uterine, Cervical)
- Head and Neck Cancers
- Lymphoma
- Leukemia
- Multiple Myeloma
- Solid Tumors
- Hematological Malignancies
- Chemotherapy (Conventional & High-Dose)
- Immunotherapy
- Targeted Therapy
- Hormonal Therapy
- Management of Oncological Emergencies
- Intrathecal Chemotherapy
- Consultation and planning for Bone Marrow Transplant
- Senior Consultant – Medical Oncology: Apollo Hospitals, Delhi (Oct 2015 – Present)
- Senior Consultant – Medical Oncology: Dharamshila Hospital & Research Centre, Delhi (May 2015 – Sep 2015)
- Consultant & Head of Department – Medical Oncology: Fortis International Oncology Centre (IOSPL), Noida (Dec 2010 – May 2015)
- Senior Resident (Medicine & Medical Oncology): Sir Ganga Ram Hospital, New Delhi (Jul 2006 – Mar 2007)
- DNB (Medical Oncology) Teacher, Apollo Hospitals, Delhi & Dharamshila Hospital
- Reviewer, South Asia Journal of Cancer
- Executive Committee Member, Indian Society of Medical & Paediatric Oncology (ISMPO)
- Joint Secretary, NCR Oncology Forum
- Organising Secretary, International Conference on Gynaecological Cancer (IOCON 2013)
- Actively involved in clinical research/trials with pharmaceutical companies.
- Spearheads content for CME programmes and focus group discussions.
- Research Project, Analysis of peripheral T-Cell lymphomas (Presented at ASCO 2010)
- Research Project, Quantitative estimation of bcr-abl transcripts in CML
- Research Project, Prognostic value of hs-CRP in acute MI
- Research Project, Ezetimibe as an adjunct to Atorvastatin in dyslipidemia
- Mentored by leading experts at AIIMS.
- Instrumental in establishing cancer centres in Tier 2 cities (e.g., Panipat) during his tenure at International Oncology.
- Developed clinical protocols and care pathways.
- Active participant in public health initiatives, awareness camps, lectures, and media discussions (TV, Radio, Print).
- Best Exam Award (Gold Medal), European Society of Medical Oncology (ESMO) Certification Exam (2013) – First Indian to achieve this award.
- President Appreciation Award, Indian Medical Association (IMA), Noida (Nov 2015) – For community work in Oncology.
- Appreciation Award, Marwari Yuva Manch (Oct 2014) – For contribution to society.
- Appreciation Award, Indian Cancer Society (Oct 2013) – For support to Cancer Sahyog volunteers.
- Adjuvant Chemotherapy in Colon Cancer: Simple is Better… Less is More (Feb 2025, South Asian Journal of Cancer)
- Indian clinical practice consensus guidelines for the management of locoregional hypopharyngeal cancer – Update 2023 (Nov 2024, Cancer Research Statistics and Treatment)
- Indian clinical practice consensus guidelines for the management of locoregional laryngeal cancer – Update 2023 (Nov 2024, Cancer Research Statistics and Treatment)
- Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer – Update 2023 (Nov 2024, Cancer Research Statistics and Treatment)
- Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck – Update 2023 (Nov 2024, Cancer Research Statistics and Treatment)
- Indian clinical practice consensus guidelines for the management of oropharyngeal cancer – Update 2023 (Nov 2024, Cancer Research Statistics and Treatment)
- Indian clinical practice consensus guidelines for the management of oral cavity cancer – Update 2023 (Nov 2024, Cancer Research Statistics and Treatment)
- Examination of genomic profile of true single circulating tumor cells (sCTC) from hepatocellular carcinoma and its effect on mutational features. (June 2024, Journal of Clinical Oncology)
- Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022 (Jan 2024, Cancer Research Statistics and Treatment)
- Language Support: Fluent in English, Hindi, and Punjabi, facilitating clear communication with a diverse patient base. Cancer Rounds team often provides interpreters for other languages if needed.
- Visa & Travel Assistance: Cancer Rounds team typically assists with visa invitation letters, travel arrangements, airport transfers, and accommodation booking.
- Pre-treatment Virtual Consultations: Dr. Singhal may be available for initial virtual consultations (teleconsultations) for international patients to review medical records and discuss potential treatment plans before travel.
- Successfully treated advanced/refractory Urothelial Cancer with novel ADC + Immunotherapy combination.
- Managed complex cases like unresectable liver cancer (cholangiocarcinoma) initially denied therapy elsewhere.
- Handled metastatic breast cancer, advanced lung cancer (Stage 4), advanced lip cancer, Gestational Trophoblastic Neoplasia (GTN), and Multiple Myeloma with positive outcomes.
- Addressed challenges arising from delayed diagnosis (e.g., large fungating breast mass).
- Patient-Centred Care: Dr. Manish believes in a compassionate, personalized approach, tailoring treatment to individual patient needs and preferences. He has strong emphasis on clear communication and patient education. He utilises the latest scientific evidence and international guidelines to inform treatment decisions.
- Technology & Innovation: Dr. Singhal employs advanced treatment modalities including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. Stays updated with cutting-edge research and advancements in oncology.He is driven by a passion for oncology, deeply influenced by his father’s long journey as a cancer warrior, viewing his profession as a calling to find cures and provide comfort.